National Institutes of Health
Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)
Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional) is a funding opportunity from National Institutes of Health. Its application deadline is not stated in the source record.
We could not verify this deadline.
This listing carries no application deadline we can confirm, so it may no longer be open. Check the official solicitation before investing time, and create a free account to see opportunities we can verify are live.
Overview
Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications that investigate the etiology of sporadic non-hereditary early-onset cancers (EOCs: ages 18 to 49 years) and the underlying biological mechanisms that play a role in these cancers to inform prevention and…